Expression pattern in human macrophages dependent on 9p21.3 coronary artery disease risk locus

Atherosclerosis

Volumn 227, Issue 2, 2013, Pages 244-249

  Zollbrecht, Christa ^a   Grassl, Martina ^a   Fenk, Sabine ^a   Höcherl, Regina ^a   Hubauer, Ute ^a   Reinhard, Wibke ^a,c   Esslinger, Ulrike B ^a   Ebert, Stefanie ^a   Langmann, Thomas ^a,b   Stark, Klaus ^a   Hengstenberg, Christian ^a,c  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atherosclerosis; Coronary artery disease; Gene expression; Inflammation; Macrophages; Myocardial infarction

Indexed keywords

CLEC4E PROTEIN; CLEC5A PROTEIN; COLONY STIMULATING FACTOR 1; CUTANEOUS T CELL ATTRACTING CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12P40; INTERLEUKIN 1B; LECTIN; LIPOPOLYSACCHARIDE; METALLOTHIONEIN; MONOCYTE CHEMOTACTIC PROTEIN 2; RNA; UNCLASSIFIED DRUG;

AGED; ALTERNATIVE RNA SPLICING; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL ISOLATION; CHROMOSOME 9P; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DENSITY GRADIENT CENTRIFUGATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LOCUS; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HOMOZYGOTE; HUMAN; IN VITRO STUDY; MALE; MONOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA ISOLATION;

ADULT; ALTERNATIVE SPLICING; CASE-CONTROL STUDIES; CHEMOKINES; CHROMOSOMES, HUMAN, PAIR 9; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HOMOZYGOTE; HUMANS; INFLAMMATION; INTERLEUKINS; LECTINS, C-TYPE; MACROPHAGES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84875051171     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.12.030     Document Type: Article

References (35)

1. Goldbourt U., Neufeld H.N. Genetic aspects of arteriosclerosis. Arteriosclerosis 1986 Jul, 6(4):357-377.
2. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 2007 Jun 7, 447(7145):661-678.
3. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007 Aug 2, 357(5):443-453.
4. Schunkert H., Gotz A., Braund P., et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008 Apr 1, 117(13):1675-1684.
5. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007 Jun 8, 316(5830):1491-1493.
6. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007 Jun 8, 316(5830):1488-1491.
7. Rivard A., Andres V. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases. Histol Histopathol 2000 Apr, 15(2):557-571.
8. Holdt L.M., Teupser D. Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler Thromb Vasc Biol 2012 Feb, 32(2):196-206.
9. Burd C.E., Jeck W.R., Liu Y., Sanoff H.K., Wang Z., Sharpless N.E. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet 2010, 6(12):e1001233.
10. Cunnington M.S., Santibanez K.M., Mayosi B.M., Burn J., Keavney B. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet 2010 Apr, 6(4):e1000899.
11. Holdt L.M., Beutner F., Scholz M., et al. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol 2010 Mar, 30(3):620-627.
12. Holdt L.M., Sass K., Gabel G., Bergert H., Thiery J., Teupser D. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Atherosclerosis 2011 Feb, 214(2):264-270.
13. Jarinova O., Stewart A.F., Roberts R., et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol 2009 Oct, 29(10):1671-1677.
14. Liu Y., Sanoff H.K., Cho H., et al. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One 2009, 4(4):e5027.
15. Lusis A.J. Atherosclerosis. Nature 2000 Sep 14, 407(6801):233-241.
16. Hamilton T.A., Adams D.O. Molecular mechanisms of signal transduction in macrophages. Immunol Today 1987, 8(5):151-158.
17. Broeckel U., Hengstenberg C., Mayer B., et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002 Feb, 30(2):210-214.
18. Fischer M., Broeckel U., Holmer S., et al. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 2005 Feb 22, 111(7):855-862.
19. Maier J.A., Statuto M., Ragnotti G. Senescence stimulates U937-endothelial cell interactions. Exp Cell Res 1993 Sep, 208(1):270-274.
20. Eisenhart C. The assumptions underlying the analysis of variance. Biometrics 1947 Mar, 3(1):1-21.
21. Thompson W.A. The problem of negative estimates of variance components. Ann Math Statist 1962, 33(1):273-289.
22. Hochberg Y., Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990 Jul, 9(7):811-818.
23. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001 May 1, 29(9):e45.
24. Zeller T., Blankenberg S., Diemert P. Genomewide association studies in cardiovascular disease - an update 2011. Clin Chem 2012 Jan, 58(1):92-103.
25. Glass C.K., Witztum J.L. Atherosclerosis. the road ahead. Cell 2001 Feb 23, 104(4):503-516.
26. Gui T., Shimokado A., Sun Y., Akasaka T., Muragaki Y. Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery. Mediators Inflamm 2012, 2012.
27. Manolio T.A., Collins F.S., Cox N.J., et al. Finding the missing heritability of complex diseases. Nature 2009 Oct 8, 461(7265):747-753.
28. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu Rev Immunol 1997, 15:675-705.
29. Braunersreuther V., Mach F., Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost 2007 May, 97(5):714-721.
30. Batliner J., Mancarelli M.M., Jenal M., et al. CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation. Mol Immunol 2011 Jan, 48(4):714-719.
31. Miyake Y., Ishikawa E., Ishikawa T., Yamasaki S. Self and nonself recognition through C-type lectin receptor, Mincle. Self Nonself 2010 Oct, 1(4):310-313.
32. Visel A., Zhu Y., May D., et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010 Mar 18, 464(7287):409-412.
33. Do R., Xie C., Zhang X., et al. The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study. PLoS Med 2011 Oct, 8(10):e1001106.
34. Harismendy O., Notani D., Song X., et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 2011 Feb 10, 470(7333):264-268.
35. Nath R., Kumar D., Li T., Singal P.K. Metallothioneins, oxidative stress and the cardiovascular system. Toxicology 2000 Nov 30, 155(1-3):17-26.